Delivery Order SPE2DB22D3016-SPE2DB24FAUB3
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $4.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic, to the Defense Logistics Agency (DLA). The $2,102.56 firm-fixed-price delivery order has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,327.87 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of January 31, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of 1,200,000 units of Bicillin L-A, a medication, to the Defense Logistics Agency (DLA). The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC is the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units of Bicillin L-A 2ml, a prescription medication, to the Defense Logistics Agency (DLA) on a firm fixed-price basis. The contract has a ceiling value of $76,391.25 and a completion date of May 7, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units of Bicillin L-A, a 2ML pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed-price contract has a ceiling value of $5,705.35 and an ultimate completion date of May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of the pharmaceutical product Bicillin L-A in 2 milliliter vials. The contract has a firm fixed price of $3,218.58 and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $27,030.75 Firm Fixed Price delivery order is for 1,200,000 units of the pharmaceutical product Bicillin L-A, 2ML. The contract has a completion date of June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,330.62 firm fixed price delivery order is for the supply of 1,200,000 units of Bicillin L-A 2ML, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, for a ceiling value of $2,166.66. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has a firm fixed price pricing type. The contract does not have a set-aside designation and is a delivery order issued under Amerisourcebergen's existing...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 1,200,000 units of the prescription medication Bicillin L-A, 2 mL, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $76,391.25, has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAUB3Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A (2 ml) to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $4,197.17 and an Ultimate Completion Date of May 1, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific contract award does not have a set-aside designation.
Generated 7/30/24, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 4/30/24 |